Posts Tagged 'false marketing'

Johnson & Johnson Guilty Plea Helps Risperdal Lawsuits

After a ten-year long criminal investigation, Johnson & Johnson has entered a guilty plea and will pay $2.2 billion in damages. The U.S. Department of Justice charged the company with promoting the drugs Risperdal and Invega for off-label uses (uses that were not approved by the FDA). These drugs were approved solely for the treatment of schizophrenia, but Johnson & Johnson was promoting them for non-schizophrenic patients—including children, ...

continue reading...

J&J to Pay Over $2.2 Billion in False Marketing Settlement

johnson and johnson marketed drugs for off-label use and false marketing claimsJohnson & Johnson (J&J) and its subsidiaries have agreed to pay over $2.2 billion in criminal and civil fines arising out of false marketing claims.  The company allegedly promoted off-label uses for various drugs, and provided kickbacks to doctors and pharmacists for prescribing those drugs. The drugs at issue in this suit include Risperdal, Invega (forms of antipsychotic medications), and Natrecor (heart failure ...

continue reading...